JP2018516254A5 - - Google Patents

Download PDF

Info

Publication number
JP2018516254A5
JP2018516254A5 JP2017561653A JP2017561653A JP2018516254A5 JP 2018516254 A5 JP2018516254 A5 JP 2018516254A5 JP 2017561653 A JP2017561653 A JP 2017561653A JP 2017561653 A JP2017561653 A JP 2017561653A JP 2018516254 A5 JP2018516254 A5 JP 2018516254A5
Authority
JP
Japan
Prior art keywords
pyrimidin
amino
methanone
phenyl
benzonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017561653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018516254A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/052825 external-priority patent/WO2016193844A1/en
Publication of JP2018516254A publication Critical patent/JP2018516254A/ja
Publication of JP2018516254A5 publication Critical patent/JP2018516254A5/ja
Pending legal-status Critical Current

Links

JP2017561653A 2015-05-29 2016-05-16 バニン1酵素の阻害薬としての新規なヘテロ環化合物 Pending JP2018516254A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562167962P 2015-05-29 2015-05-29
US62/167,962 2015-05-29
US201562195005P 2015-07-21 2015-07-21
US62/195,005 2015-07-21
PCT/IB2016/052825 WO2016193844A1 (en) 2015-05-29 2016-05-16 Novel heterocyclic compounds as inhibitors of vanin-1 enzyme

Publications (2)

Publication Number Publication Date
JP2018516254A JP2018516254A (ja) 2018-06-21
JP2018516254A5 true JP2018516254A5 (enExample) 2019-05-23

Family

ID=56026933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017561653A Pending JP2018516254A (ja) 2015-05-29 2016-05-16 バニン1酵素の阻害薬としての新規なヘテロ環化合物

Country Status (5)

Country Link
US (2) US10308615B2 (enExample)
EP (1) EP3303303A1 (enExample)
JP (1) JP2018516254A (enExample)
CA (1) CA2987179C (enExample)
WO (1) WO2016193844A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10906888B2 (en) 2016-07-14 2021-02-02 Pfizer Inc. Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
US10961242B2 (en) * 2017-05-17 2021-03-30 Legochem Biosciences, Inc. Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same
KR101798840B1 (ko) 2017-05-17 2017-11-17 주식회사 레고켐 바이오사이언스 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물
AU2018285131B2 (en) * 2017-06-12 2021-11-11 Boehringer Ingelheim International Gmbh Heteroaromatic compounds as Vanin inhibitors
US11723929B2 (en) 2017-06-13 2023-08-15 The Regents Of The University Of California Methods of improving cell-based therapy
US10702488B2 (en) * 2017-12-19 2020-07-07 Theriac Biomedical Inc. PPAR-γ activators, HDAC inhibitors and their therapeutical usages
US11497723B1 (en) * 2017-12-19 2022-11-15 Tony Antakly PPAR-gamma activators, HDAC inhibitors and their therapeutical usages
WO2019133445A1 (en) * 2017-12-28 2019-07-04 Inception Ibd, Inc. Aminothiazoles as inhibitors of vanin-1
HUE061186T2 (hu) 2018-08-28 2023-06-28 Boehringer Ingelheim Int Heteroaromás vegyületek mint vanin-inhibitorok
WO2020102575A1 (en) * 2018-11-16 2020-05-22 Inception Ibd, Inc. Heterocyclic aminothiazoles and uses thereof
JP7130873B2 (ja) * 2018-12-03 2022-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング バニン阻害剤としてのヘテロ芳香族化合物
ES2928919T3 (es) * 2018-12-03 2022-11-23 Boehringer Ingelheim Int Compuestos heteroaromáticos como inhibidores de vanina
BR112021010823A2 (pt) * 2018-12-03 2021-08-24 Boehringer Ingelheim International Gmbh Compostos heteroaromáticos como inibidores de vanina
EP4054556A4 (en) * 2019-11-07 2023-11-29 Increvet, Inc. SODIUM-GLUCOSE-LINKED TRANSPORTER INHIBITORS FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE, HYPERTENSION AND HEART FAILURE IN PETS
WO2022081716A1 (en) * 2020-10-13 2022-04-21 Accubit LLC - Biotechnology Methods of treating iga nephropathy with thiol-containing molecules
US20240124479A1 (en) * 2020-12-17 2024-04-18 Shanghai Meiyue Biotech Development Co. Ltd Pyrimidine carboxamide compound and use thereof
CN120247898B (zh) * 2025-03-31 2026-07-14 大连医科大学附属第二医院 一种噻吩甲酰胺类化合物及其用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
ID26984A (id) 1998-07-06 2001-02-22 Bristol Myers Squibb Co Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
WO2003072197A1 (en) 2002-02-27 2003-09-04 Pfizer Products Inc. Acc inhibitors
EA011086B9 (ru) 2004-05-12 2012-08-30 Пфайзер Продактс Инк. Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv
EP2010520B1 (en) 2006-04-20 2012-09-12 Pfizer Products Inc. Heterobicyclic amides for the prevention and treatment of glucokinase-mediated diseases
WO2008063888A2 (en) * 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
WO2008065508A1 (en) 2006-11-29 2008-06-05 Pfizer Products Inc. Spiroketone acetyl-coa carboxylase inhibitors
US20090036425A1 (en) 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
US8158636B2 (en) * 2008-05-19 2012-04-17 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP2297164A1 (en) 2008-05-28 2011-03-23 Pfizer Inc. Pyrazolospiroketone acetyl-coa carboxylase inhibitors
JP5435592B2 (ja) 2008-05-28 2014-03-05 ファイザー・インク ピラゾロスピロケトンアセチルCoAカルボキシラーゼ阻害剤
CA2729581A1 (en) 2008-07-29 2010-02-04 Pfizer Inc. Fluorinated heteroaryls
ES2380408T3 (es) 2008-08-28 2012-05-11 Pfizer Inc. Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
TW201038580A (en) 2009-02-02 2010-11-01 Pfizer 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
WO2010103437A1 (en) 2009-03-11 2010-09-16 Pfizer Inc. Benzofuranyl derivatives used as glucokinase inhibitors
EP2406230A1 (en) 2009-03-11 2012-01-18 Pfizer Inc. Substituted indazole amides and their use as glucokinase activators
CA2754523A1 (en) 2009-03-20 2010-09-23 Pfizer Inc. 3-oxa-7-azabicyclo[3.3.1]nonanes
CA2759843A1 (en) 2009-05-08 2010-11-10 Pfizer Inc. Gpr 119 modulators
EP2427448A1 (en) 2009-05-08 2012-03-14 Pfizer Inc. Gpr 119 modulators
GEP20135907B (en) 2009-06-05 2013-08-12 Pfizer L-(piperidin-4-yl)-pyrazole derivatives as gpr 119 modulators
WO2011005611A1 (en) 2009-07-09 2011-01-13 Merck Sharp & Dohme Corp. Neuromedin u receptor agonists and uses thereof
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
TWI525090B (zh) * 2010-04-27 2016-03-11 Mitsubishi Tanabe Pharma Corp Novel amide derivatives and their use as pharmaceuticals
CA2836474A1 (en) 2011-05-17 2012-11-22 Plexxikon Inc. Kinase modulation and indications therefor
EP2736329A4 (en) 2011-07-29 2015-03-25 Tempero Pharmaceuticals Inc COMPOUNDS AND METHODS
WO2013151938A1 (en) 2012-04-02 2013-10-10 Cytokinetics, Inc. Methods for improving diaphragm function
US9585891B2 (en) 2012-09-25 2017-03-07 Merck Patent Gmbh Alpha hydroxy amides

Similar Documents

Publication Publication Date Title
RU2008141509A (ru) Mglur5 модуляторы 1
RU2452738C2 (ru) Соединения, модулирующие активность c-fms и/или c-kit, и их применения
JP2014531465A5 (enExample)
HRP20110939T1 (hr) Supstituirani benzimidazoli kao inhibitori kinaze
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
RU2009125620A (ru) Органические соединения
JP2009519967A5 (enExample)
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2013544840A5 (enExample)
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2005516934A5 (enExample)
JP2015536320A5 (enExample)
JP2019524705A5 (enExample)
RU2014153626A (ru) Пиридиноновые и пиридазиноновые производные
JP2016519096A5 (enExample)
JP2020526547A5 (enExample)
HRP20141190T1 (hr) Disupstituirani derivati piridina kao antikancerogena sredstva
RU2015143517A (ru) Пиразолсодержащие соединения и их применения
JP2008507564A5 (enExample)
JP2018535999A5 (enExample)
RU2010125220A (ru) Ненуклеозидные ингибиторы обратной транскриптазы
JP2013528591A5 (enExample)
JP2020500192A5 (enExample)
HRP20200098T1 (hr) Spirociklični spojevi kao inhibitori triptofan hidroksilaze